VERV
VOYA Investment Management’s Verve Therapeutics VERV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $213K | Sell |
18,937
-730
| -4% | -$8.2K | ﹤0.01% | 2304 |
|
|
2025
Q1 | $89.9K | Sell |
19,667
-2,494
| -11% | -$11.4K | ﹤0.01% | 2456 |
|
|
2024
Q4 | $125K | Sell |
22,161
-1,538
| -6% | -$8.67K | ﹤0.01% | 2523 |
|
|
2024
Q3 | $115K | Buy |
23,699
+155
| +0.7% | +$750 | ﹤0.01% | 2629 |
|
|
2024
Q2 | $115K | Buy |
23,544
+2,803
| +14% | +$13.7K | ﹤0.01% | 2634 |
|
|
2024
Q1 | $275K | Buy |
20,741
+42
| +0.2% | +$558 | ﹤0.01% | 2292 |
|
|
2023
Q4 | $289K | Buy |
20,699
+302
| +1% | +$4.21K | ﹤0.01% | 2371 |
|
|
2023
Q3 | $270K | Buy |
20,397
+375
| +2% | +$4.97K | ﹤0.01% | 2356 |
|
|
2023
Q2 | $375K | Buy |
20,022
+2,085
| +12% | +$39.1K | ﹤0.01% | 2246 |
|
|
2023
Q1 | $259K | Hold |
17,937
| – | – | ﹤0.01% | 2401 |
|
|
2022
Q4 | $347K | Buy |
17,937
+599
| +3% | +$11.6K | ﹤0.01% | 2232 |
|
|
2022
Q3 | $596K | Buy |
17,338
+3,690
| +27% | +$127K | ﹤0.01% | 1919 |
|
|
2022
Q2 | $209K | Buy |
+13,648
| New | +$209K | ﹤0.01% | 2374 |
|
|
2022
Q1 | – | Sell |
-6,074
| Closed | -$224K | – | 2758 |
|
|
2021
Q4 | $224K | Sell |
6,074
-202
| -3% | -$7.45K | ﹤0.01% | 2444 |
|
|
2021
Q3 | $295K | Buy |
+6,276
| New | +$295K | ﹤0.01% | 2355 |
|